Nervonik announced today that it completed the first-in-human clinical study of its peripheral nerve stimulation (PNS) device ...

Orthocell’s US FDA 510(k) regulatory study of peripheral nerve-repair product Remplir has met all endpoints. ... Read More ...

Although scientists estimate that more than 230 million people worldwide suffer from Peripheral Artery Disease, it is often ...

After posting "oustanding" pivotal trial data, Orthocell will apply for US FDA approval of its Remplir nerve-repair product.

When Renerve makes its IPO on the ASX today, it will join Orthocell as one of only two nerve-repair companies to be listed on ...

The following is a summary of “Local molecular signature of human peripheral neuropathic pain,” published in the November ...

Local companies picked for the University City Science Center bootcamp include one developing a robotic surgical system and ...

Scientists examine the effectiveness of an antibody targeting cell adhesion molecule 1 in alleviating pain-induced neuronal ...

A new study from Michigan Medicine suggests that following a low-calorie diet and doing high-intensity exercise could reduce ...

Results of a small study suggest similar pathophysiology of cognitive dysfunction and neuropathic pain in patients with long COVID.